Management of Thrombosis in the Cancer Patient


Upon viewing this session, you will be able to determine the epidemiologic and pathophysiologic underpinnings of cancer-related thrombosis, assess the performance of the Khorana score in predicting the 6-month risk of VTE and analyze the efficacy and safety of LMWH among cancer patients with a "high-risk" score, summarize the evidence for LMWH and DOACS in treatment of venous thromboembolism in cancer patients, and describe specific challenging scenarios in the management of cancer-associated thrombosis.


  • Anita Rajasekhar


Member Type Price
List Price $100.00
Active, International, Emeritus, and Honorary Members $50.00
Associate, International Associate, Student, and Resident Members $25.00
back to top